Prevention of Recurrence in Depression With Drugs and CT

PHASE4CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

July 31, 2012

Study Completion Date

March 31, 2014

Conditions
Depression
Interventions
BEHAVIORAL

Cognitive Therapy

CT sessions occur weekly during acute treatment and monthly during continuation. Acute treatment may last up to 18 months. Remitted patients are continued on medication for up to 36 months from initial randomization until they meet criteria for recovery. At recovery, patients receiving combined treatment discontinue CT.

DRUG

Medications

Antidepressant medication is distributed as clinically indicated with augmentation and ancillary medications as needed. Acute treatment may last up to 18 months. Remitted patients are continued on medication for up to 36 months from the point of initial randomization until they meet criteria for recovery. All recovered patients are randomized a second time to either maintenance medication or medication withdrawal. Patients are then monitored over 36 months to ascertain risk for recurrence of depressive symptoms.

Trial Locations (3)

19104

Depression Research Unit, University of Pennsylvania, Philadelphia

37203

Vanderbilt Adult Outpatient Psychiatry, Nashville

60612

Rush Medical Center - Treatment Research Unit, Chicago

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Vanderbilt University

OTHER

NCT00057577 - Prevention of Recurrence in Depression With Drugs and CT | Biotech Hunter | Biotech Hunter